Alarming Slowdown in EU R&D Investment: Health and Energy Sectors Buck the Trend
The latest 2025 EU Industrial R&D Investment Scoreboard paints a concerning picture: overall R&D investment growth among EU companies is slowing down. But here's where it gets interesting: the European health and energy sectors are defying this trend, ramping up their R&D spending well above their global counterparts. This annual report, a collaborative effort between the European Commission’s Joint Research Centre and the Directorate General Research & Innovation since 2004, offers a treasure trove of economic insights. It analyzes the financial accounts of the world’s top 2,000 R&D investors, including an extended sample of the top 800 EU-based companies. Collectively, these firms account for a staggering 90% of global private R&D funding.
EU’s Mixed Bag: Health and Energy Shine, ICT and Automotive Stall
In 2024, EU-headquartered companies invested a total of €233.8 billion in R&D, marking a modest 2.9% growth rate—a significant drop from the 9.3% seen in 2023. However, not all sectors are feeling the pinch. The health sector saw a remarkable 13% increase in R&D investments, outpacing regions like the United States (7.1%), Japan (9.1%), and China (0.1%). Similarly, the energy sector, particularly in electricity and renewable energy, surged by 19.8%, leaving global competitors in the dust. The United States, Japan, and China trailed behind with growth rates of 6%, -14.2%, and 3.8%, respectively.
And this is the part most people miss: while the health and energy sectors are thriving, others are struggling. The EU’s ICT sector saw an 8.9% decline in investments, and the automotive industry, the EU’s largest R&D investor at €87 billion, barely grew at 0.8%. This stagnation pales in comparison to China’s 11.9% and Japan’s 12.3% growth rates in the same sector.
Global R&D Landscape: Concentration of Power and Innovation
Globally, R&D investment continues to climb, with the top 2,000 companies investing €1,442.6 billion in 2024, a 6.3% increase. The United States and the rest of the world led the charge with growth rates of 7.8% and 8.1%, respectively, followed by Japan at 7.1%. The EU’s growth, at 2.9%, was more subdued, mirroring China’s 3.9%.
Controversial Question: Is Innovation Becoming Too Centralized?
Here’s a bold point to ponder: global R&D investment is increasingly concentrated among a handful of tech giants—Amazon, Alphabet, Meta, Microsoft, and Apple. Over the past decade, these five companies have doubled their share of global R&D investment, now controlling approximately 15% of the total. This concentration is mirrored in their profits, which surged from 3% to 15% between 2011 and 2024. While this consolidation drives innovation, it raises critical questions about market dynamism and the diffusion of innovation across the global economy. Are we risking a monopoly on creativity and progress?
Open Data for All: Empowering Stakeholders
The Scoreboard isn’t just a report; it’s a powerful benchmarking tool. Based on data extracted directly from company annual reports, it allows for detailed comparisons across companies, sectors, and regions. Its annual publication has become a cornerstone for science, industry, and policymakers, contributing to influential reports like the Draghi and Heitor Reports, the Science, Research & Innovation Performance Report, and the European Investment Bank Investment Reports.
In the spirit of open science, the Scoreboard’s dataset is publicly available, enabling stakeholders to conduct their own analyses and monitoring. This transparency aligns with the Commission’s commitment to open science practices, fostering collaboration and innovation across the board.
Explore Further: Dive into the Data
Curious to dig deeper? The full report, dataset, and an interactive visual dashboard are available on the JRC’s Economics of Industrial Research and Innovation webpage. Whether you’re a policymaker, researcher, or industry professional, this resource is a goldmine for understanding global R&D trends.
Final Thought: What’s Your Take?
As R&D investment becomes increasingly concentrated, what does this mean for smaller players and emerging markets? Is this centralization a necessary evil for rapid innovation, or does it stifle competition and creativity? Share your thoughts in the comments—let’s spark a conversation!
